ArticleCancer biology & therapy2018
The CHK1 inhibitor SRA737 synergizes with PARP1 inhibitors to kill carcinoma cells.
Laurence Booth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it
ArticleCancer biology & therapy2018
Laurence Booth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.